JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $600,854 | +51.8% | 324,786 | -8.9% | 0.00% | – |
| Q4 2022 | $395,868 | -49.2% | 356,638 | +7.0% | 0.00% | – |
| Q3 2022 | $779,000 | -33.9% | 333,156 | -14.4% | 0.00% | – |
| Q2 2022 | $1,179,000 | -47.8% | 389,280 | +17.0% | 0.00% | – |
| Q1 2022 | $2,258,000 | -22.0% | 332,588 | -4.1% | 0.00% | – |
| Q4 2021 | $2,894,000 | +11.1% | 346,722 | -1.1% | 0.00% | – |
| Q3 2021 | $2,605,000 | -10.5% | 350,647 | -18.1% | 0.00% | -100.0% |
| Q2 2021 | $2,909,000 | +12.1% | 427,885 | +69.4% | 0.00% | – |
| Q1 2021 | $2,594,000 | +18.1% | 252,600 | -19.5% | 0.00% | – |
| Q4 2020 | $2,196,000 | -13.1% | 313,640 | +1.3% | 0.00% | -100.0% |
| Q3 2020 | $2,526,000 | +13.3% | 309,571 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $2,230,000 | +139.3% | 323,172 | +64.6% | 0.00% | – |
| Q1 2020 | $932,000 | -38.2% | 196,279 | +13.7% | 0.00% | – |
| Q4 2019 | $1,507,000 | +150.3% | 172,593 | -4.5% | 0.00% | – |
| Q3 2019 | $602,000 | -35.8% | 180,757 | -4.5% | 0.00% | – |
| Q2 2019 | $937,000 | -17.7% | 189,363 | +3.0% | 0.00% | – |
| Q1 2019 | $1,139,000 | +84.0% | 183,759 | -0.0% | 0.00% | – |
| Q4 2018 | $619,000 | -48.7% | 183,824 | -1.0% | 0.00% | – |
| Q3 2018 | $1,206,000 | -2.4% | 185,679 | +15.1% | 0.00% | – |
| Q2 2018 | $1,236,000 | -62.0% | 161,357 | +10.8% | 0.00% | -100.0% |
| Q1 2018 | $3,256,000 | +70.0% | 145,673 | -3.0% | 0.00% | – |
| Q4 2017 | $1,915,000 | -15.0% | 150,185 | +3.9% | 0.00% | -100.0% |
| Q3 2017 | $2,252,000 | +77.5% | 144,579 | +59.9% | 0.00% | – |
| Q2 2017 | $1,269,000 | +73.4% | 90,412 | +171.6% | 0.00% | – |
| Q1 2017 | $732,000 | – | 33,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |